Clinical Trials

Nursing home operator Principle LTC and Care Access, a research organization, have launched a new research hub in Raleigh, NC, to provide rural residents access to clinical trials.

The pharmaceutical firm Biogen has stopped a real-world clinical trial for its federally approved Alzheimer’s disease drug aducanumab (Aduhelm).

Two commonly used autoimmune drugs could be used in addition to standard-of-care treatments to improve COVID-19 outcomes, the agency says.

Principle LTC, operator of 45 nursing homes in the Southeast, is building on its successful role in testing a key drug for COVID-19 prevention and treatment to launch trials of a new Alzheimer drug.

The organization is making an effort to connect a broader and more diverse set of candidates to clinical trials.

Clinical trial partnerships could help assisted living change “long-term care” narrative … Number of nurse practitioners increases 9% since May … Experimental drug halves death rate in critically...

Coverage of aducanumab (Aduhelm) is officially limited to clinical trials only, the agency announced Thursday. Most stakeholders have called for restricted use while more efficacy and safety data is gathered,...

A third dose of Pfizer-BioNTech’s vaccine restores protection against the disease to levels achieved after the second dose, a large new trial shows.

Clinical trials for new COVID-19 antiviral drugs are expected to wrap up by winter, sparking hopes that a daily pill to treat COVID-19 infection is closer to fruition, according to a new report.

The drugs, each given orally as a pill, would provide an unprecedented COVID-19 preventive medication option if brought to market.